:一种药用,在胃肠道癌症中具有益生菌和抗癌潜力
Akshay Shankar1, Yashika Sharma2, Mahak Rastogi3
1Division of Molecular Biology, ICMR-National Institute of Cancer Prevention and Research, Noida, India.
药用Ganoderma lucidum在预防胃肠道癌症方面显示出潜在的潜力. 它的生物活性化合物和多糖类作为益生菌,增强肠道健康和增强免疫力.
科学领域:
- 菌类学 菌类学是指菌类学.
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
背景情况:
- 药用Ganoderma lucidum因其通过调节肠道微生物群来改善肠道健康的能力而闻名.
- 它是生物活性代谢物,抗氧化剂和酶的丰富来源,有助于功能性食品,营养和制药.
- 来自G. lucidum的多糖类具有前生物潜力,促进有益的肠道微生物的生长.
研究的目的:
- 审查白色腐烂基菌体代谢物对结直肠癌治疗的影响.
- 探索甘 (Ganoderma lucidum) 和其他药用作为食补充剂的治疗潜力.
- 专注于这些对肠道微生物和胃肠道癌症的影响.
主要方法:
- 从PubMed,谷歌学者和ResearchGate的研究进行了全面的文献综述.
- 对Ganoderma lucidum代谢物的影响现有数据的分析.
- 以清晰的表格呈现发现,以便理解.
主要成果:
- 在体内和体外的研究表明,Ganoderma lucidum作为胃肠道癌症抑制剂的潜力.
- 机制包括诱导亲细胞灭绝,自,G0/G1细胞循环停止和免疫调节.
- 生物活性代谢物和多糖体表现出前生物效应,促进有益的肠道细菌.
结论:
- 光的生物活性化合物和多糖类提供了益生菌的益处,通过修改肠道细菌,可能降低胃肠道癌症风险.
- 这些益生菌性质可以增强免疫力,减少炎症,改善肠道屏障功能.
- 药用如Ganoderma lucidum作为肠道健康和癌症预防的食补充剂具有治疗前景.
更多相关视频
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
06:07Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
Published on: June 13, 2020
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Ulcerative Colitis in IBD
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
